Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer
Juan Liu, Cen Zhang, Dandan Xu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Translating p53-based therapies for cancer into the clinic
Sylvain Peuget, Xiaolei Zhou, Galina Selivanova
Nature reviews. Cancer (2024) Vol. 24, Iss. 3, pp. 192-215
Closed Access | Times Cited: 55
Nanoscale Metal–Organic Frameworks‐Mediated Degradation of Mutant p53 Proteins and Activation of cGAS‐STING Pathway for Enhanced Cancer Immunotherapy
Li Sun, Hongbo Gao, Han Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 12
Open Access | Times Cited: 16
TRIM21‐Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers
Jun Gong, Yuhui Liu, Wenjia Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 29
Open Access | Times Cited: 23
An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer
Lingping Kong, Fanlu Meng, Ping Zhou, et al.
Science Bulletin (2024) Vol. 69, Iss. 13, pp. 2122-2135
Open Access | Times Cited: 10
TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1/NRF2 pathway
Bo Yu, Yu Zhou, He J
Cell Cycle (2023) Vol. 22, Iss. 12, pp. 1496-1513
Open Access | Times Cited: 17
TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer
Wenlong Ye, Long Huang, Xiaoqin Yang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Open Access | Times Cited: 7
CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription
Z.H Wang, Yaming Li, H. J. Yang, et al.
Advanced Science (2024)
Open Access | Times Cited: 6
Targeting mutant p53 stabilization for cancer therapy
Jiajian Wang, Wenjun Liu, Lanqing Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion
Yuan Wang, Ineza Karambizi Sandrine, Li Ma, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 5
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
A. Awan, Maryiam Jama Ali Osman, Omar M. Khan
Cells (2025) Vol. 14, Iss. 2, pp. 69-69
Open Access
PTOV1 exerts pro-oncogenic role in colorectal cancer by modulating SQSTM1-mediated autophagic degradation of p53
Yongli Fan, Yuqin Li, Xia Luo, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications
Sayan Mullick Chowdhury, Feng Hong, Christian Rolfo, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 214-214
Open Access
Lipogenic enzyme FASN promotes mutant p53 accumulation and gain-of-function through palmitoylation
Juan Liu, Yiyun Shen, Jie Liu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Lactylation-driven transcriptional activation of FBXO33 promotes gallbladder cancer metastasis by regulating p53 polyubiquitination
Zhenheng Wu, You Peng, Wen Chen, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death
D. H. Zhang, Songze Song, Jing Lin, et al.
Developmental Cell (2025)
Closed Access
KDM1A-Driven RNF81 Downregulation Promotes Gastric Cancer Progression via KLF4 Destabilization
Steve Jiang, Feng Wang, Po Hao, et al.
Research Square (Research Square) (2025)
Closed Access
The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren’s syndrome, cancers, and cancer metabolism
Chueh-Hsuan Hsu, Yung‐Luen Yu
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
MiR-99a-3p downregulates TRIM21 to promote gastric cancer development
Ling He, Jiaoli Zhou, Doukun Ding, et al.
Molecular and Cellular Biochemistry (2024)
Open Access | Times Cited: 3
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
Dafei Chai, Junhao Wang, Chunmei Fan, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions
Marco Cordani, Alessia Garufi, Rossella Benedetti, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 649-649
Open Access | Times Cited: 2
p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications
Dixan A. Benitez, Guadalupe Cumplido-Laso, Marcos Olivera-Gómez, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1453-1453
Open Access | Times Cited: 2
Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53
Rossella Benedetti, Michele Di Crosta, Gabriella D’Orazi, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 508-508
Open Access | Times Cited: 2
MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression
Jie Liu, Xujin Wei, Yixuan Xie, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 2
Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer
Jianing Cao, Mengdi Yang, Duancheng Guo, et al.
Cancer Medicine (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 1
Ubiquitination in osteosarcoma: unveiling the impact on cell biology and therapeutic strategies
Jianlin Shen, Yue Lai, Yanjiao Wu, et al.
Cancer Biology and Medicine (2024) Vol. 21, Iss. 10, pp. 880-897
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top